SCHEMBL916231

SCHEMBL916231

CCCC(=O)C(C(=O)O)C(O)(CC(=O)O)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPD1 P10809 1/20 0.49
BLM P54132 1/20 0.49
HSPE1 P61604 1/20 0.49
CPT2 P23786 1/20 0.48
ACLY P53396 1/20 0.48
FFAR3 O14843 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
MEN1 O00255 1/20 0.35
HPGD P15428 1/20 0.35
RECQL P46063 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ALDH1A1 P00352 1/20 0.34
HMGCR P04035 1/20 0.34
CHRM1 P11229 1/20 0.34
TBXA2R P21731 1/20 0.34
ADRA1A P35348 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28009119 0.90 HSPD1 (0.54) HSPD1BLMHSPE1CPT2ACLY
SCHEMBL9242157 0.87 HSPD1 (0.59) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL28185680 0.87 HSPD1 (0.59) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL9237884 0.87 HSPD1 (0.59) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL9241752 0.87 HSPD1 (0.59) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL9244443 0.87 HSPD1 (0.59) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL7184136 0.87 HSPD1 (0.59) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL9243955 0.87 HSPD1 (0.59) HSPD1BLMHSPE1MEN1HPGD
SCHEMBL20472740 0.85 ACLY (0.52) HSPD1BLMHSPE1CPT2ACLY
Butyric Acid SCHEMBL587501 0.83 HSPD1 (0.46) HSPD1BLMHSPE1CPT2ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3185904-B1 COLLOIDAL DISPERSION COMPRISING HPMCAS CAPSUGEL BELGIUM NV (BE) 2020-02-26 EP claimed
CN-106638049-B Asepsis environment-protecting suitable for embedding oxygen polyimide material is plasticized carrier and its application 仪征市海帆化工有限公司 2019-05-17 CN claimed
CN-109438874-A A kind of high-strength and high ductility polyvinyl chloride injection moulding composition and preparation method thereof 宜宾天原集团股份有限公司 2019-03-08 CN claimed
WO-2018033621-A1 COMPOSITION FOR PREPARING AN ELECTROCHROMIC LAYER BASF SE (DE) 2018-02-22 WO claimed
CN-107337874-A A kind of PVC/LDPE drug packing materials and preparation method thereof 江苏凯威药用包装有限公司 2017-11-10 CN claimed
CN-107325438-A It is a kind of for pvc material of medical package and preparation method thereof 江苏凯威药用包装有限公司 2017-11-07 CN claimed
CN-107253845-A The wear-resisting engineering material of multifunctional fire-proof 苏州伟安杰工程技术有限公司 2017-10-17 CN claimed
CN-106638049-A Nontoxic environment-friendly plastifying carrier applicable to oxygen embedded polyimide material and application of nontoxic environment-friendly plastifying carrier 仪征市海帆化工有限公司 2017-05-10 CN claimed
CN-104004488-B A kind of environment-friendly type end-silicane-group polymerization of acrylic modified polyurethane electronic seal glue 江苏矽时代材料科技有限公司 2017-01-04 CN claimed
CN-104371223-A High-temperature-resistant anti-adhesion medical PVC material and preparation method thereof SHANGHAI NEW SHANGHUA POLYMER MATERIAL CO LTD 2015-02-25 CN claimed
CN-101371824-A Oral cavity pasting tablets using Methylprednisolone and derivatives thereof as active components TIANJIN PHARMACEUTICALS GROUP (CN) 2009-02-25 CN claimed
CN-101371825-A Oral sticking tablets using fluticasone propionate as active component TIANJIN PHARMACEUTICALS GROUP (CN) 2009-02-25 CN claimed
US-20060134044-A1 Cosmetic composition comprising a sequenced polymer and a plasticizer L'OREAL (FR) 2006-06-22 US claimed
WO-2005058257-A1 POLYMER AND PLASTICISER-CONTAINING COSMETIC COMPOUND L'OREAL (FR) 2005-06-30 WO claimed
EP-1545440-A2 COSMETIC COMPOSITION COMPRISING A SEQUENCED POLYMER AND A PLASTICIZER L'OREAL (FR) 2005-06-29 EP claimed
EP-1477153-A1 Cosmetic composition comprising a dispersion of polymer particles with it's plasticizer L'OREAL (FR) 2004-11-17 EP claimed
CN-1535675-A Cosmetic omposition containing polymer granules dispersion and plasticizing polymer compound 莱雅公司 2004-10-13 CN claimed
WO-2004028490-A2 COSMETIC COMPOSITION COMPRISING A SEQUENCED POLYMER AND A PLASTICIZER L'ORÉAL (FR) 2004-04-08 WO claimed
CN-1332016-A Biodegradable carrier and biodegradable delivery system A J SCHUCKRA (US) 2002-01-23 CN claimed
EP-0138147-B1 CITRATE-ESTER PLASTICIZED PVC BLOOD CONTAINERS Bayer Corporation (US) 1993-04-14 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060134044-A1 Cosmetic composition comprising a sequenced polymer and a plasticizer NFKB1, NFKB2, POLL HSPD1 3819/4885BLM 1734/4885HSPE1 3758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.